4//SEC Filing
Kessler Paul D. 4
Accession 0001455244-11-000002
CIK 0000072444other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 3:16 PM ET
Size
5.5 KB
Accession
0001455244-11-000002
Insider Transaction Report
Form 4
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Transactions
- Sale
Common Stock
2011-01-05$5.65/sh−2,985$16,869→ 95,267 total
Footnotes (2)
- [F1]This disposition was made to fund the Reporting Person's tax obligation arising from the vesting of restricted stock.
- [F2]This disposition was effected pursuant to a 10b5-1 trading plan.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001428524
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 3:16 PM ET
- Size
- 5.5 KB